NetworkNewsBreaks

TuesdaySep 10, 2024 11:25 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Names Seasoned Veteran as New EVP of Commercial Operations

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has appointed a new executive vice president of commercial operations, effective immediately. According to the announcement, the company named Thomas (Tom) Englese as its new executive, noting that he has more than two decades of commercial and operations experience in the biopharmaceutical industry. The company also noted that it is on track to submit an NDA for TNX-102 SL for fibromyalgia in October 2024. “Tom brings extraordinary biopharmaceutical expertise as an industry leader with more than 20 years of commercial experience and a proven…

Continue Reading

TuesdaySep 10, 2024 11:11 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has named a seasoned medtech leader as its new chief financial officer. According to the announcement, Timothy Cruickshank has accepted the role of chief financial officer, effective immediately; he succeeds Richard Brounstein, who announced his retirement. Cruickshank has a proven track record of strategic planning, financial stewardship and commercial success with a focus on growing businesses with disruptive technologies through authentic leadership, strategic focus, data-driven decisions, and strong risk management and governance. “Tim has an outstanding record of delivering results and creating…

Continue Reading

TuesdaySep 10, 2024 11:04 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Announces Successful Acquisition of CarryoutSupplies.com

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, today announced the closing of its strategic all-stock acquisition of SWC Group Inc. (d/b/a CarryoutSupplies.com), a leading wholesaler and distributor of custom takeout packaging for the foodservice industry. The acquisition enhances Nightfood’s operational efficiencies, expands its product offerings and customer base, and allows for synergistic growth opportunities. According to the announcement, the closing of the acquisition marks a pivotal moment in the company’s growth and Nasdaq-uplist strategy. “We are thrilled to announce the successful acquisition of CarryoutSupplies.com and excited for what we believe this acquisition will allow Nightfood to…

Continue Reading

MondaySep 09, 2024 2:12 pm

NetworkNewsBreaks – Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Spotlighted in Latest Episode of The MiningNewsWire Podcast

Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH), an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West gold project, is featured in the latest episode of The MiningNewsWire Podcast. Alex Horsley, Head of Corporate Development of Emperor Metals, joined the episode to discuss the 2011 mineral resource estimate (“MRE”) for the Duquesne West gold project, as well as the company’s recent milestones and near-term goals. “Our mission is to grow this resource as quickly, cost efficiently and strategically as possible. Our resource was based on a 3.0-gram cutoff grade…

Continue Reading

MondaySep 09, 2024 1:11 pm

NetworkNewsBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Integrates with Apple Wallet to Expand In-Store Payment Solutions

PayPal (NASDAQ: PYPL) is making a strategic leap into the in-store payment landscape by integrating its services with Apple Inc.’s (NASDAQ: AAPL) Apple Wallet, launching the “PayPal Everywhere” solution. This move is designed to bridge the gap between online and physical retail, allowing PayPal to tap into the vast in-store payment market. By offering a seamless omnichannel payment experience, PayPal is not just expanding its user base but also enhancing the utility of its platform beyond the confines of e-commerce. The introduction of a rewards program that offers 5% cash back on a chosen monthly spending category further incentivizes users…

Continue Reading

MondaySep 09, 2024 1:09 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Featured Guest on Latest Episode of BioMedWire Podcast

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is spotlighted in this week’s episode of The BioMedWire Podcast. During the episode, Scinai Immunotherapeutics CEO Amir Reichman talks with host Carmel Fisher about SCNI’s business model as well as entities and experts the company works closely with. The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. “In the end, we went for a derisking strategy where our molecular targets are molecular…

Continue Reading

MondaySep 09, 2024 12:40 pm

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data Demonstrating TNX-801’s Single-Dose Immune Protection Against Mpox

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, is announcing data presented at an immunology symposium at the University of Alberta. Titled “Using Synthetic Biology to Battle Mpox,” the presentation detailed positive preclinical data on Tonix’s vaccine platform, led by TNX-801, an attenuated live-virus vaccine based on synthesized horsepox, for preventing mpox (formerly known as monkeypox). TNX-801 has been shown to provide animals with single-dose immune protection against a lethal challenge with clade I monkeypox. New data also shows that TNX-801 has better tolerability than 20th century vaccinia live-virus vaccines in…

Continue Reading

MondaySep 09, 2024 11:46 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Achieves ‘Important Accomplishment’ with CARB Certification

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has received certification from the California Air Resources Board (“CARB”) for its B4 all-electric, Class 4 low forward chassis truck. The CARB certification is a requirement to sell vehicles in California, Colorado, Connecticut, Delaware, Maine, Maryland, Massachusetts, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, Vermont and the District of Columbia. According to the announcement, the certification opens B4 EV truck customers to federal and state incentives of up to $100,000. Bollinger plans to start production of the B4 on September…

Continue Reading

MondaySep 09, 2024 11:42 am

NetworkNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) Announces New Software Update for Lucid Air

Lucid Group (NASDAQ: LCID), maker of the world's most-advanced electric vehicles, unveiled a major software update for its flagship vehicle, the Lucid Air. The update — Lucid UX 2.4 — features an enhanced version of DreamDrive Pro, Lucid's optional Advanced Driver Assistance System (“ADAS”) that offers more than a dozen updates and enhanced capabilities such as new 3D lane visualization; Lucid Assistant, a new voice control system; and an updated map design for improved legibility. “Lucid UX 2.4 introduces an array of new features and improvements to make every trip more satisfying,” said Lucid head of software engineering Dr. Jean-Philippe Gauthier in the…

Continue Reading

MondaySep 09, 2024 9:39 am

NetworkNewsBreaks – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Plans Preclinical Studies for Treatment of Monkey Pox

TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, is focused on beginning Proof of Concept preclinical studies to evaluate its lead therapeutic TCB 008 for treatment in monkey pox. According to the announcement, TCBP will partner with a leading infectious disease center or university associated with a similar organization to advance the studies as quickly as possible. “There are a number of academic papers highlighting a successful immune response to viral infection being heavily reliant on the presence of gamma delta t-cells,” said TC BioPharm CEO Bryan Kobel in the press…

Continue Reading